activity
20082025
most cited- and -Learning Methods for Estimating Optimal Dynamic Treatment Regimes

183 citations · 272 across the 13 of their papers we have counts for

collaborators

13 papers

stat.ME2025

Independent increments and group sequential tests

Anastasios A. Tsiatis, Marie Davidian

Widely used methods and software for group sequential tests of a null hypothesis of no treatment difference that allow for early stopping of a clinical trial depend primarily on th…

stat.ME2024

A Generalized Logrank-type Test for Comparison of Treatment Regimes in Sequential Multiple Assignment Randomized Trials

Anastasios A. Tsiatis, Marie Davidian

The sequential multiple assignment randomized trial (SMART) is the ideal study design for the evaluation of multistage treatment regimes, which comprise sequential decision rules t…

stat.ME2024

Adaptive Randomization Methods for Sequential Multiple Assignment Randomized Trials (SMARTs) via Thompson Sampling

Peter Norwood, Marie Davidian, Eric Laber

Response-adaptive randomization (RAR) has been studied extensively in conventional, single-stage clinical trials, where it has been shown to yield ethical and statistical benefits,…

stat.ME2022★ 7 cited

Interim Monitoring of Sequential Multiple Assignment Randomized Trials Using Partial Information

Cole Manschot, Eric Laber, Marie Davidian

The sequential multiple assignment randomized trial (SMART) is the gold standard trial design to generate data for the evaluation of multi-stage treatment regimes. As with conventi…

stat.ME2022★ 1 cited

Group sequential methods for interim monitoring of randomized clinical trials with time-lagged outcome

Anastasios A. Tsiatis, Marie Davidian

The primary analysis in two-arm clinical trials usually involves inference on a scalar treatment effect parameter; e.g., depending on the outcome, the difference of treatment-speci…

stat.ME2021★ 1 cited

Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial

Anastasios A. Tsiatis, Marie Davidian, Shannon T. Holloway

In many randomized clinical trials of therapeutics for COVID-19, the primary outcome is an ordinal categorical variable, and interest focuses on the odds ratio (active agent vs. co…